Antitumor activity of Xiaoaiping injection on human gastric cancer SGC-7901 cells

Chinese Journal of Natural Medicines

Volumn 10, Issue 5, 2012, Pages 339-346

  Koumtebaye, Elysee ^a   Su, Nan ^a   Hu, Wan Feng ^a   Lin, Sen Sen ^a   Sun, Li ^a   Yuan, Sheng Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antitumor; Apoptosis; SGC 7901 cells; Xiaoaiping

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CASPASE 3; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; XIAOAIPING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84866879707     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(12)60068-5     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin 2011, 61:69.
2. Sintara K, Thong-Ngam D Gastric cancer: the experimental models [J]. Thai J Physiol Sci 2008, 21(1):31-38.
3. Wang BQ, Jin ZX Agrimoniin induced SGC7901 cell apoptosis associated mitochondrial transmembrane potential and intracellular calcium concentration [J]. J Medl Plants Res 2011, 5(15):3513-3519.
4. Pisani P, Parkin DM, Ferlay J Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden [J]. Int J Cancer 1993, 55:891-903.
5. Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005 [J]. Cancer Epidemiol Biomarkers Prev 2005, 14:243-250.
6. Gusani NJ, Jiang Y, Kimchi ET, et al. New pharmacological developments in the treatment of hepatocellular cancer [J]. Drugs 2009, 6(18):2533-2540.
7. Zhang MX, Zhang HL, Sun CY, et al. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B [J]. Cancer Chemother Pharmacol 2009, 63:635-642.
8. Newman DJ, Cragg GM Advanced preclinical and clinical trials of natural products and related compounds from marine sources [J]. Curr Med Chem 2004, 11(13):1693-1713.
9. van Loo G, Saelens X, van Gurp M, et al. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet [J]. Cell Death Differ 2002, 9:1031-1042.
10. Kevin A Janes, Suzanne Gaudet, John G Albeck, et al. The response of human epithelial cells to TNF involves an inducible sutocrine vascade [J]. Cell 2006, 124(6):1225-1239.
11. Grever MCB Cancer drug discovery and development. Cancer: Principles and Practice of Oncology 2001, 328-339. Lippincott-Raven, Philadelphia, PA. V.H.S. De Vita, S.A. Rosenberg (Eds.).
12. Zhang MZ, He Z, Wu GY, et al. Effect of xiaoaiping injection on Ec-9706 cell line [J]. Lishizhen Med Mater Med Res 2008, 19(5):1182-1184.
13. Wang SM, Zhao HP Inhibitory effect of xiaoaiping injection combined with octreotide acetate on transplanted liver cancer in mice [J]. Chin J Clin Oncol 2011, 38(18):1135-1138.
14. Ramasamy S, Abdul Wahab N, Zainal Abidin N, et al. Effect of extracts from Phyllanthus watsonii Airy Shaw on cell apoptosis in cultured human breast cancer MCF-7 cells [J]. Exp Toxicol Pathol 2012, 35(1):98-104.
15. Goel A, Boland CR, Chauhan DP Speci?c inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells [J]. Cancer Lett 2001, 172:111-118.
16. Rastogi RP, Richa, Sinha RP Apoptosis: molecular mechanisms and pathogenicity [J]. EXCLI J 2009, 8:155-181.
17. Cheng LY, Liu M, Wang CC, et al. CI431, an aqueous compound from Ciona intestinalis L., induces apoptosis through a mitochondria-mediated pathway in human hepato-cellular carcinoma cells [J]. Evidence-Based Complement Alternat Med 2011, 10.1155/2011/292873.
18. Tayarani-Najaran Z, Parsaee H, Hoseini A, et al. Study of noscapine-induced cell death in hepatocellular carcinoma cell line [J]. Pharmacologyonline 2009, 3:522-530.
19. Kaur M, Velmurugan B, Tyagi A, et al. Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft [J]. Molecular Cancer Therapeutics 2009, 8(8):2366-2374.
20. Xu H, Wen YP, Zhao W, et al. In vitro anti tumor activity of Sesamum indicum Linn flower extracts [J]. Trop J Pharma Res 2010, 9(5):455-462.
21. 1 cells arrest in HCT 116 and HT 29 colon cancer cell lines [J]. African J Biochem Res 2010, 4(4):134-142.
22. Teng BS, Lu YH, Wang ZT, et al. In vitro antitumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells [J]. Pharmacol Res 2006, 54(3):186-194.
23. Logue SE, Martin SJ Caspase activation cascades in apoptosis [J]. Biochem Soc Trans 2008, 36:1-9.
24. Jiang XJ, Wang XD Cytochrome c-mediated apoptosis [J]. Annu Rev Biochem 2004, 73:87-106.
25. Giovanni C, Evasio P, Deodato A, et al. Effects of acute caffeine administration on NOS and Bax/Bcl-2 expression in the myocardium of rat [J]. Pharmacol Res 2008, 57(1):19-25.
26. Rundle CH, Wang XG, Matilda H, et al. Bax deficiency in mice increases cartilage production during fracture repair through a mechanism involving increased chondrocyte Proliferation without changes in apoptosis [J]. Bone 2008, 43:880-888.
27. Jia J, Lu R, Qiu S, et al. Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402 [J]. Cancer Biol Ther 2005, 4(9):993-997.
28. Correia-da-Silva G, Bell SC, Pringle JH, et al. Patterns of expression of Bax, Bcl-2 and Bcl-x L in the implantation site in rat during pregnancy [J]. Placenta 2005, 26(10):796-806.
29. Wang CH, Tang CW, Liu CL, et al. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway [J]. World J Gastroenterol 2003, 9(9):1904-1908.
30. Oliver G, Stefan T, Robert A, et al. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins [J]. J Nat Cancer Instit 2001, 93(6):463-471.
31. Paradiso A, Simone G, De Lena M, et al. Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer [J]. British J Cancer 2001, 84(5):651-658.